Symmetry Medical (SMA) Updates FY13 Earnings Guidance

Symmetry Medical (NYSE: SMA) issued an update on its FY13 earnings guidance on Monday morning. The company provided EPS guidance of $0.40-0.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.63, Stock Ratings Network.com reports. The company issued revenue guidance of $400-415 million, compared to the consensus revenue estimate of $426.94 million.Symmetry Medical also updated its Q2 guidance to $0.06-0.08 EPS.

Symmetry Medical (NYSE: SMA) traded down 0.76% on Monday, hitting $9.17. Symmetry Medical has a 1-year low of $7.48 and a 1-year high of $12.83. The stock’s 50-day moving average is currently $10.. The company has a market cap of $341.8 million and a price-to-earnings ratio of 41.81.

Symmetry Medical (NYSE: SMA) last issued its quarterly earnings data on Thursday, May 2nd. The company reported $0.06 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.15 by $0.09. The company had revenue of $98.90 million for the quarter, compared to the consensus estimate of $106.04 million. During the same quarter in the prior year, the company posted $0.09 earnings per share. The company’s quarterly revenue was down 1.8% on a year-over-year basis. Symmetry Medical has set its FY13 guidance at $0.64-0.76 EPS. Analysts expect that Symmetry Medical will post $0.63 EPS for the current fiscal year.

A number of analysts have recently weighed in on SMA shares. Analysts at TheStreet downgraded shares of Symmetry Medical from a buy rating to a hold rating in a research note to investors on Tuesday, May 7th. On a related note, analysts at Zacks reiterated a neutral rating on shares of Symmetry Medical in a research note to investors on Monday, May 6th. They now have a $11.00 price target on the stock. Finally, analysts at Benchmark Co. cut their price target on shares of Symmetry Medical from $16.00 to $14.00 in a research note to investors on Friday, May 3rd. They now have a buy rating on the stock.

Symmetry Medical Inc. (NYSE: SMA) is an independent provider of implants and related instruments and cases to global orthopedic device manufacturers.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2017 Ticker Report. Google+.